Humana (HUM) Tops Q2 EPS by 41c, Lifts FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Humana (HUM) PT Raised to $230 at Cantor Fitzgerald Following 2Q Release
August 2, 2017 1:17 PM EDTCantor Fitzgerald raised its price target on Humana (NYSE: HUM) to $230.00 (from $200.00) while maintaining a Neutral rating following the company's 2Q earnings report. Non-GAAP EPS was $3.49 vs. recast 2Q16 nonGAAP EPS of $3.29. Medicare revenue grew 3.3% y/y compared to 1.2% in 1Q17.
The company... More
